These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23807983)

  • 1. [PrenaTest].
    Velev R; Mircheva M
    Akush Ginekol (Sofiia); 2013; 52(2):60-1. PubMed ID: 23807983
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal serum triple analyte screening in pregnancy.
    Cate S
    Am Fam Physician; 2000 Aug; 62(4):738, 740. PubMed ID: 10969855
    [No Abstract]   [Full Text] [Related]  

  • 3. Trisomy 21 DNA test (MaterniT21) for detecting Down syndrome in the first trimester.
    Manag Care; 2012 Apr; 21(4):19-20. PubMed ID: 22593849
    [No Abstract]   [Full Text] [Related]  

  • 4. Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.
    Kloza EM
    Birth Defects Orig Artic Ser; 1990; 26(3):31-43. PubMed ID: 1709365
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid aneuploidy test for positive Down screening: who is willing to pay for it?
    Lo TK; Leung WC; Lau WL; Lam H; Lai FK; Ng LS; Wong WC; Chan A; Chin RK
    J Matern Fetal Neonatal Med; 2010 Jul; 23(7):747-9. PubMed ID: 19701862
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Malone FD
    Obstet Gynecol; 2005 Feb; 105(2):438; author reply 438-9. PubMed ID: 15684179
    [No Abstract]   [Full Text] [Related]  

  • 7. Maternal serum screening.
    Lofsky S
    CMAJ; 1999 Apr; 160(8):1125-6. PubMed ID: 10234332
    [No Abstract]   [Full Text] [Related]  

  • 8. Prenatal diagnosis now and in the future, in a genetic perspective.
    Wahlström J
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):925-7. PubMed ID: 11081672
    [No Abstract]   [Full Text] [Related]  

  • 9. Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?
    Bianchi DW; Oepkes D; Ghidini A
    Prenat Diagn; 2014 Jan; 34(1):6-11. PubMed ID: 24002925
    [No Abstract]   [Full Text] [Related]  

  • 10. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Screening for fetal chromosomal anomalies--recent aspects].
    Simon-Bouy B
    Gynecol Obstet Fertil; 2000 Feb; 28(2):152-4. PubMed ID: 10758590
    [No Abstract]   [Full Text] [Related]  

  • 12. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal screening for Down syndrome.
    Wald NJ
    Prog Clin Biol Res; 1995; 393():27-42. PubMed ID: 8545455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A parent's guide to the genetics of Down syndrome.
    Hartway S
    Adv Neonatal Care; 2009 Feb; 9(1):27-30. PubMed ID: 19212162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Options for Down syndrome screening: what will women choose?
    Grant SS
    J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down syndrome screening: imagining the screening test of the future.
    Koster MP; Heetkamp KM; Pennings JL; de Vries A; Visser GH; Schielen PC
    Expert Rev Mol Diagn; 2010 May; 10(4):445-57. PubMed ID: 20465499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal tests for Down syndrome.
    American College of Nurse-Midwives
    J Midwifery Womens Health; 2005; 50(3):255-6. PubMed ID: 15895013
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of oxidant-antioxidant system indices in forming groups at high genetic risk].
    Arbuzova SB; Fedotova OO; Malova SA; Krasnov AV
    Tsitol Genet; 1999; 33(4):77-80. PubMed ID: 10563382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the extent of information desired by women undergoing non-invasive prenatal testing following positive prenatal Down-syndrome screening test results.
    Lo TK; Chan KY; Kan AS; So PL; Kong CW; Mak SL; Lee CN
    Int J Gynaecol Obstet; 2017 Jun; 137(3):338-339. PubMed ID: 28295291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.